U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904325) titled 'Vascular Health and Function in Cystic Fibrosis' on Sept. 25.
Brief Summary: The goal of this observational study is to learn whether blood vessel health and function differ between adults aged 40 years or older with cystic fibrosis (CF) who are taking CFTR modulator therapy and healthy adults of the same age and sex. As people with CF now live longer, they may face a higher risk of heart and blood vessel disease and stroke.
The main question it aims to answer is:
Is the function of the arteries in the arm (measured by radial artery flow-mediated dilation and low-flow mediated constriction) reduced in people with CF compared with ...